98. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature. 2008;455:1129–33. 99. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64:6892–9. 100. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, et al. p53 mutations are associ- ated with 17p allelic loss in grade II and grade III astrocy- toma. Cancer Res. 1992;52:2987–90. 101. Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell. 2007;12: 303–12. 102. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, et al. Glioblastoma subclasses can be deﬁned by activity among signal transduction pathways and associated genomic alterations. PLoS ONE. 2009;4: e7752. 103. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high- grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157–73. 104. Robertson T, Koszyca B, Gonzales M. Overview and recent advances in neuropathology. Part 1: Central nervous system tumours. Pathology. 2011;43:88–92. 105. Brennan C. Genomic proﬁles of glioma. Curr Neurol Neu- rosci Rep. 2011;11:291–7. 106. Huse JT, Phillips HS, Brennan CW. Molecular subclassiﬁ- cation of diffuse gliomas: seeing order in the chaos. Glia. 2011;59:1190–9. 107. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncol- ogy: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60:166–93. 108. Altman J. Are new neurons formed in the brains of adult mammals? Science. 1962;135:1127–8. 109. Morshead CM, Reynolds BA, Craig CG, McBurney MW, Staines WA, Morassutti D, et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopu- lation of subependymal cells. Neuron. 1994;13:1071–82. 110. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707–10. 111. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, et al. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science. 2007;315:1243–9. 112. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez- Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999;97:703–16. 113. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J. Identiﬁcation of a neural stem cell in the adult mammalian central nervous system. Cell. 1999;96:25–34. 114. Merkle FT, Tramontin AD, García-Verdugo JM, Alvarez- Buylla A. Radial glia give rise to adult neural stem cells in the subventricular zone. Proc Natl Acad Sci USA. 2004;101: 17528–32. 115. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci. 2004;26:148–65. 116. Suh H, Consiglio A, Ray J, Sawai T, D’Amour KA, Gage FH. In vivo fate analysis reveals the multipotent and PDGF and PDGF receptors in glioma 111 self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell. 2007;1:515–28. 117. Favaro R, Valotta M, Ferri AL, Latorre E, Mariani J, Giachino C, et al. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci. 2009;12:1248–56. 118. Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A, et al. Sox2 deﬁciency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Devel- opment. 2004;131:3805–19. 119. Doetsch F. A niche for adult neural stem cells. Curr Opin Genet Dev. 2003;13:543–50. 120. Riquelme PA, Drapeau E, Doetsch F. Brain micro-ecologies: neural stem cell niches in the adult mammalian brain. Philos Trans R Soc Lond B Biol Sci. 2008;363:123–37. 121. Ramírez-Castillejo C, Sánchez-Sánchez F, Andreu-Agulló C, Ferrón SR, Aroca-Aguilar JD, Sánchez P, et al. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci. 2006;9:331–9. 122. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science. 2004; 304:1338–40. 123. Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A. EGF converts transit-amplifying neuro- genic precursors in the adult brain into multipotent stem cells. Neuron. 2002;36:1021–34. 124. Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, van der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell popula- tions in the adult mouse brain. J Neurosci. 1996;16: 2649–58. 125. Erlandsson A, Enarsson M, Forsberg-Nilsson K. Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci. 2001;21: 3483–91. 126. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and ﬁbroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 1997;17:5820–9. 127. Gonzalez-Perez O, Romero-Rodriguez R, Soriano- Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Epider- mal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendro- cytes. Stem Cells. 2009;27:2032–43. 128. Bachoo RM, Maher EH, Ligon KL, Sharpless NE, Chan SS, You MJ, et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 2002;1:269–77. 129. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001;15:1913–25. 130. D’Sa-Eipper C, Leonard JR, Putcha G, Zheng TS, Flavell RA, Rakic P, et al. DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development. 2001;128:137–46. 131. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR. High-frequency developmental abnormalities in p53-deﬁcient mice. Curr Biol. 1995;5:931–6. 132. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. A subset of p53-deﬁcient embryos exhibit exencephaly. Nat Genet. 1995;10:175–80.